Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders??? Equity

v3.24.3
Condensed Consolidated Statements of Changes in Shareholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   42,445,517    
Beginning balance at Dec. 31, 2022 $ 100,999 $ 424 $ 360,155 $ (259,580)
Increase (Decrease) in Stockholders' Equity        
Net loss (17,823)     (17,823)
Stock-based compensation 13,091   13,091  
Issuance of restricted and performance stock units (in shares)   356,236    
Issuance of restricted and performance stock units   $ 4 (4)  
Exercise of stock options and employee stock purchase plan (in shares)   237,646    
Exercise of stock options and employee stock purchase plan 1,543 $ 2 1,541  
Ending balance (in shares) at Sep. 30, 2023   43,039,399    
Ending balance at Sep. 30, 2023 97,810 $ 430 374,783 (277,403)
Beginning balance (in shares) at Jun. 30, 2023   42,979,541    
Beginning balance at Jun. 30, 2023 97,152 $ 430 370,036 (273,314)
Increase (Decrease) in Stockholders' Equity        
Net loss (4,089)     (4,089)
Stock-based compensation 4,747   4,747  
Issuance of restricted and performance stock units (in shares)   59,858    
Ending balance (in shares) at Sep. 30, 2023   43,039,399    
Ending balance at Sep. 30, 2023 $ 97,810 $ 430 374,783 (277,403)
Beginning balance (in shares) at Dec. 31, 2023 43,124,496 43,124,496    
Beginning balance at Dec. 31, 2023 $ 95,665 $ 431 376,530 (281,296)
Increase (Decrease) in Stockholders' Equity        
Net loss (10,414)     (10,414)
Stock-based compensation 12,830   12,830  
Issuance of restricted and performance stock units (in shares)   695,571    
Issuance of restricted and performance stock units   $ 7 (7)  
Exercise of stock options and employee stock purchase plan (in shares)   182,256    
Exercise of stock options and employee stock purchase plan $ 1,326 $ 2 1,324  
Ending balance (in shares) at Sep. 30, 2024 44,002,323 44,002,323    
Ending balance at Sep. 30, 2024 $ 99,407 $ 440 390,677 (291,710)
Beginning balance (in shares) at Jun. 30, 2024   43,824,738    
Beginning balance at Jun. 30, 2024 95,687 $ 438 385,101 (289,852)
Increase (Decrease) in Stockholders' Equity        
Net loss (1,858)     (1,858)
Stock-based compensation 5,004   5,004  
Issuance of restricted and performance stock units (in shares)   112,185    
Issuance of restricted and performance stock units   $ 1 (1)  
Exercise of stock options and employee stock purchase plan (in shares)   65,400    
Exercise of stock options and employee stock purchase plan $ 574 $ 1 573  
Ending balance (in shares) at Sep. 30, 2024 44,002,323 44,002,323    
Ending balance at Sep. 30, 2024 $ 99,407 $ 440 $ 390,677 $ (291,710)